The other studies either used a B cell lymphoma (52) which, as a transformed cell, possibly displays aberrant signaling properties, or employed ERK activated by a constitutively active form of RAF (45). This evidence concerns the gene MAPK1 and B-cell non-Hodgkin lymphoma.